Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 548f-2 (MIR548F2) is a small non-coding RNA molecule (miRNA) that plays a role in the post-transcriptional regulation of gene expression in multicellular organisms[1]. It is transcribed from its gene locus as a precursor that undergoes enzymatic processing (by Drosha and Dicer) to yield a mature miRNA, which is incorporated into the RISC complex. The mature miRNA regulates cellular pathways by binding to complementary sequences in target mRNAs, leading to translational repression or mRNA degradation[1]. Emerging evidence implicates the miR-548F family (including miR-548F-2 and closely related members) in cancer biology, particularly in processes such as cell cycle control, proliferation, and cytoskeletal organization, with strong evidence in triple-negative breast cancer. However, direct evidence on MIR548F2-specific mechanisms and disease associations remains limited; most functional and disease associations are extrapolated from family members and broader miRNA research[2].
MicroRNA-mediated gene silencing; RNA-induced silencing complex (RISC) targeting of mRNAs for degradation or translational repression[1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 548f-2 (MIR548F2).